Brought to you by 
CFR Pharma buys Adcock Ingram for $1.26bn; combo to cover major emerging markets; terminated
25 Sep 2020
Executive Summary
Chile’s CFR Pharmaceuticals SA (specialty branded generics) is acquiring publicly traded South African drug manufacturer, marketer, and distributor Adcock Ingram Holdings Ltd. for ZAR12.6bn ($1.26bn).
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
Deal Status
- Withdrawn
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CFR Pharma buys Adcock Ingram for $1.26bn; combo to cover major emerging markets; terminated
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice